Assignee
CORMORANT PHARMACEUTICALS AB
SE·3 granted patents·1 pending application·8 citations·filing 2016–2022
Top patents by PatentIndex Score
4 records- 0192US11339215B2Methods of treating cancer with human monoclonal antibodies against interleukin 8 (IL-8)CORMORANT PHARMACEUTICALS AB·Filed 2019·Granted May 24, 2022·4 cites·19 claims
- 0283US10253093B2Human monoclonal antibodies against interleukin 8 (IL-8)CORMORANT PHARMACEUTICALS AB·Filed 2018·Granted Apr 9, 2019·2 cites·15 claims
- 0382US10066012B2Human monoclonal antibodies against interleukin 8 (IL-8)CORMORANT PHARMACEUTICALS AB·Filed 2016·Granted Sep 4, 2018·2 cites·15 claims
- 0480US2023042255A1Human monoclonal antibodies against interleukin 8 (il-8)CORMORANT PHARMACEUTICALS AB·Filed 2022·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when CORMORANT PHARMACEUTICALS AB files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →